Pharma and Biotech Services

We work closely together with many pharmaceutical & biotech companies, especially in target discovery and indication selection. We enable a data-driven understanding of disease biology by leveraging computational disease models based on AI technologies such as machine reading and learning. We connect data science, translational biology and access to our AI Platform with our customer's disease & drug development expertise to gain collaborative disease insights.

Enabling world leading pharma, biotech and academic institutions
Genmab
Janssen and Janssen Pharmaceutical Companies
Leiden Academic Centre for Drug Research
Astra Zeneca
Boehringer Ingelheim
Logo Sanofi-1
Euretos
Disease Modelling

AI driven computational disease models

Euretos has created AI driven computational disease models that have been tried and tested with many leading pharma and biotech companies. The disease models predict novel target-indication combinations by assessing whether a target’s biological interactors are linked to known disease associations. Domain experts can then review these predictions independently in the Euretos AI Platform and draw evidence based conclusions.
Euretos
Services

Indication Selection

Discover and evaluate novel potential indications for your target of interest predicted using AI driven computational disease models.

Go to the Euretos Science Exchange store to request a quote on-line!        science exchange logo

 

Euretos
Services

Target Discovery

Discover and evaluate novel potential targets for your disorder of interest predicted using AI driven computational disease models.
Enabling world leading pharma, biotech and academic institutions
Logo Johnson & Johnson-1
Logo Grunenthal-2
Logo Daiichi Sankyo-1
Logo Pivot Park
Logo Sanofi
Logo EMC
Euretos Indication Expansion-2
Client review

Indication Selection

"“In this project we evaluated you against our internal investigations and the results of one other external provider. What really sets you apart is how you combine a fundamentally biological and data driven approach. The breadth of the indications you assess and the depth of your analysis sets you apart and is a clear value add to our internal capabilities.” "

Global Head Large European Pharma
Euretos Target discovery-2
Client review

Target Discovery

"“We worked with Euretos to leverage their AI capabilities with the aim of finding new targets in two different indications. It was a real pleasure to work with them and the whole process was characterized by transparency, their willingness to listen to our needs and suggestions, and swift responses and data delivery. In addition, we found their platform very useful for getting an overview of the different targets and for general inquiries.“"

Tau Benned-Jensen Senior Research Scientist, H. Lundbeck A/S
Euretos Biomarker discovery
Client review

Target Assessment

""We are fascinated by the suggested hypothesis. It was great that even very small expressional changes were captured and a hypothesis was generated. The interpretation was also convincing and consistent. Also the team is well engaged, and had a very good understanding in the background of the project and our research question""

Principal Scientist Large Japanese Pharma
Euretos AI platform on laptop
Client review

Euretos AI Platform

"I find the Euretos platform to be valuable in what it offers in terms of advanced AI capabilities and analytics of smart scouting and literature searches to probe relevant targets, indications, and therapeutics. The professional support and dedicated mentoring from experienced bioinformatics professionals that Euretos offers greatly enhances our ability to take advantage of all the capabilities of the platform, and extract meaningful insights for our day to day mission of bringing innovation into Teva."

Dr. Dana Bar-On Sr. Director, Head of Academic Affairs and Networks, Specialty R&D, Teva Pharmaceuticals
Euretos Target discovery-2
Client review

Target Discovery

"We have been working with Euretos for many years now. They provide us with unique tools that we use as an integral part of our target discovery and validation. Using the Euretos AI platform is a mandatory input to our target evaluation meetings."

Associate Director Target Discovery Large European Biotech
Euretos Indication Expansion-2
Client review

Indication Selection

"We find that the Euretos group was very easy to work with and communicate with. The professional staff at Euretos did a great job extending their bioinformatics platform and capabilities to our advantage. Euretos helped us to extract meaningful information from a highly complex data domain, that we could build on internally."

Henriette Husum Bak-Jensen Project Manager, Projects & Portfolio department, H. Lundbeck A/S

Transforming Disease and Drug Research

Get started Free access for academic users!
Book a demo